Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Overnight Post-Exercise Recovery After Protein Ingestion Prior to Sleep

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00991523
Recruitment Status : Completed
First Posted : October 8, 2009
Last Update Posted : April 20, 2011
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Maastricht University Medical Center

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to examine the effects of post-exercise protein ingestion prior to sleep on overnight protein kinetics and muscle recovery.

Condition or disease Intervention/treatment Phase
Exercise Resistance Training Dietary Supplement: protein Dietary Supplement: placebo Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 24 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Basic Science
Official Title: Protein Ingestion Prior to Sleep as a Dietary Strategy to Improve Post-exercise, Overnight Recovery.
Study Start Date : October 2009
Actual Primary Completion Date : August 2010
Actual Study Completion Date : December 2010
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: sweetened beverage Dietary Supplement: protein
protein
Placebo Comparator: placebo control
placebo
 Dietary Supplement: placebo
placebo control


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. muscle protein synthesis [ Time Frame: 10 hours ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male
  • Age between 20 and 30 years
  • Healthy, recreationally active
  • BMI <25 kg/m2

Exclusion Criteria:

  • Use of medication
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00991523


Locations
Layout table for location information
Netherlands
Maastricht MUMC
Maastricht, LI, Netherlands, 6202
MaastrichtUMC
Maastricht, Netherlands
Sponsors and Collaborators
Maastricht University Medical Center
GlaxoSmithKline
Investigators
Layout table for investigator information
Principal Investigator: Luc van Loon, PhD Maastricht University Medical Center
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Luc van Loon, University Hospital Maastricht
ClinicalTrials.gov Identifier: NCT00991523    
Other Study ID Numbers: MEC 09-3-054
First Posted: October 8, 2009    Key Record Dates
Last Update Posted: April 20, 2011
Last Verified: April 2011
Keywords provided by Maastricht University Medical Center:
resistance
exercise
protein
recovery